What was Vivos’s price range in the past 12 months?
Vivos lowest stock price was $0.04 and its highest was $0.12 in the past 12 months.
What is Vivos’s market cap?
Vivos’s market cap is $22.14M.
When is Vivos’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Vivos overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Vivos pay dividends?
Vivos does not currently pay dividends.
What is Vivos’s EPS estimate?
Vivos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vivos have?
Vivos has 494,214,360 shares outstanding.
Which hedge fund is a major shareholder of Vivos?
Currently, no hedge funds are holding shares in RDGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vivos
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.